Home › Funds › Bellevue Group AG › LBRX
Bellevue Group AG position in LBRX
LB PHARMACEUTICALS INC · Health Care
Bellevue Group AG reported holding 715,513 shares of LBRX (LB PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$27.5M, representing 0.57% of its reported portfolio and ranking #43 among its reported holdings. Bellevue Group AG first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's LBRX position evolved
Bellevue Group AG first disclosed a stake in LBRX in Q3 2026 at 715,513 shares (US$27.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 715.51K | $27.46M | New |
About LBRX and 13F data
LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 102 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$128.7M), RA CAPITAL MANAGEMENT, L.P. (US$84.8M), Spruce Street Capital LP (US$53.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LBRX
- Deep Track Capital, LP 3.35M sh · $128.68M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 2.21M sh · $84.77M · Q3 2026
- Spruce Street Capital LP 1.40M sh · $53.86M · Q3 2026
- Caligan Partners LP 1.51M sh · $49.62M · Q3 2026
- Commodore Capital LP 1.28M sh · $49.21M · Q3 2026
- Trails Edge Capital Partners, LP 1.15M sh · $44.11M · Q3 2026
- Nantahala Capital Management, LLC 1.07M sh · $41.23M · Q3 2026
- Vivo Capital, LLC 800.00K sh · $30.70M · Q3 2026
- TCG Crossover Management, LLC 765.05K sh · $29.36M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 741.41K sh · $28.46M · Q3 2026
- Nan Fung Group Holdings Ltd 630.66K sh · $24.20M · Q3 2026
- Integral Health Asset Management, LLC 470.00K sh · $18.04M · Q3 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held LBRX?
Bellevue Group AG has disclosed LBRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Bellevue Group AG's current position in LBRX?
As of Q3 2026, Bellevue Group AG holds 715.51K shares of LBRX (LB PHARMACEUTICALS INC), valued at $27.46M, representing 0.57% of its reported portfolio and ranking #43.
Has Bellevue Group AG been buying or selling LBRX?
In the latest 13F filing (Q3 2026), Bellevue Group AG newly opened its position in LBRX.
Which other funds hold LBRX?
Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Spruce Street Capital LP, among 102 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.